Kurome Therapeutics closes $15 million Series A financing
Funding to develop targeted kinase inhibitors for treatment of hematopoietic cancers Kurome Therapeutics, a preclinical stage company dedicated to developing ...
Tag: IRAK1/4 signaling pathway
POPULAR NEWS
-
Scientists Investigate Possible Connection Between COVID-19 and Increased Lung Cancer Risk
-
NSF funds machine-learning research at UNO and UNL to study energy requirements of walking in older adults
-
Boosting Breast Cancer Risk Prediction with Genetics
-
Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
